Log in

China Biologic Products SEC Filings & 10K Form (NASDAQ:CBPO)

$116.93
+0.11 (+0.09 %)
(As of 02/23/2020 01:01 PM ET)
Today's Range
$116.39
Now: $116.93
$116.97
50-Day Range
$115.35
MA: $116.42
$117.57
52-Week Range
$79.13
Now: $116.93
$119.44
Volume79,901 shs
Average Volume90,790 shs
Market Capitalization$4.60 billion
P/E Ratio28.66
Dividend YieldN/A
Beta1.16

SEC Filings

China Biologic Products (NASDAQ:CBPO) SEC Filings

DateFilerForm TypeView
01/24/2020
7:00 AM
China Biologic Products (Subject)
PW Medtech Group Ltd (Filed by)
Form SC 13D/A
01/24/2020
6:58 AM
China Biologic Products (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13D/A
01/24/2020
6:48 AM
China Biologic Products (Subject)
CITIC Capital Holdings Ltd (Filed by)
Form SC 13D/A
01/24/2020
5:54 AM
Centurium Capital Partners 2018, L.P. (Filed by)
China Biologic Products (Subject)
Form SC 13D/A
12/10/2019
1:19 PM
Capital Research Global Investors (Filed by)
China Biologic Products (Subject)
Form SC 13G/A
11/18/2019
8:06 AM
Centurium Capital Partners 2018, L.P. (Filed by)
China Biologic Products (Subject)
Form SC 13D/A
11/06/2019
2:56 PM
China Biologic Products (Subject)
Parfield International Ltd (Filed by)
Form SC 13D/A
10/17/2019
7:31 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2019
7:39 AM
China Biologic Products (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13D
09/26/2019
7:24 PM
China Biologic Products (Subject)
Parfield International Ltd (Filed by)
Form SC 13D
09/24/2019
7:30 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2019
5:30 AM
China Biologic Products (Subject)
CITIC Capital Holdings Ltd (Filed by)
Form SC 13D/A
09/19/2019
3:30 PM
China Biologic Products (Subject)
HILLHOUSE CAPITAL ADVISORS, LTD. (Filed by)
Form SC 13D
09/19/2019
7:32 AM
Centurium Capital Partners 2018, L.P. (Filed by)
China Biologic Products (Subject)
Form SC 13D/A
09/19/2019
6:43 AM
China Biologic Products (Subject)
PW Medtech Group Ltd (Filed by)
Form SC 13D/A
09/19/2019
5:09 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/10/2019
11:56 AM
Capital Research Global Investors (Filed by)
China Biologic Products (Subject)
Form SC 13G/A
08/05/2019
4:01 PM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2019
3:30 PM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2019
3:31 PM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2019
4:00 PM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2019
3:45 PM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2019
3:14 PM
Centurium Capital Partners 2018, L.P. (Filed by)
China Biologic Products (Subject)
Form SC 13D/A
03/06/2019
4:15 PM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2019
2:08 PM
China Biologic Products (Subject)
Hillhouse Capital Advisors, Ltd. (Filed by)
Form SC 13G/A
02/12/2019
2:00 PM
China Biologic Products (Subject)
Parfield International Ltd (Filed by)
Form SC 13G/A
02/04/2019
7:00 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2019
5:12 AM
Centurium Capital Partners 2018, L.P. (Filed by)
China Biologic Products (Subject)
Form SC 13D/A
01/08/2019
7:00 AM
Centurium Capital Partners 2018, L.P. (Filed by)
China Biologic Products (Subject)
Form SC 13D/A
01/07/2019
7:31 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2018
6:07 AM
Centurium Capital Partners 2018, L.P. (Filed by)
China Biologic Products (Subject)
Form SC 13D/A
12/14/2018
7:30 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/19/2018
5:12 AM
Centurium Capital Partners 2018, L.P. (Filed by)
China Biologic Products (Subject)
Form SC 13D/A
11/09/2018
2:35 PM
Capital Research Global Investors (Filed by)
China Biologic Products (Subject)
Form SC 13G/A
11/01/2018
4:00 PM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2018
5:03 AM
China Biologic Products (Subject)
CITIC Capital Holdings Ltd (Filed by)
Form SC 13D/A
10/16/2018
5:41 AM
China Biologic Products (Subject)
CITIC Capital Holdings Ltd (Filed by)
Form SC 13D/A
09/24/2018
7:26 AM
China Biologic Products (Subject)
PW Medtech Group Ltd (Filed by)
Form SC 13D/A
09/21/2018
3:10 PM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/14/2018
5:03 AM
Centurium Capital Partners 2018, L.P. (Filed by)
China Biologic Products (Subject)
Form SC 13D
09/04/2018
4:15 PM
China Biologic Products (Subject)
Hillhouse Capital Management, Ltd. (Filed by)
Form SC 13G
09/04/2018
3:05 PM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/28/2018
4:15 PM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2018
8:15 AM
China Biologic Products (Subject)
PW Medtech Group Ltd (Filed by)
Form SC 13D/A
08/27/2018
7:56 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2018
7:23 AM
China Biologic Products (Subject)
CITIC Capital Holdings Ltd (Filed by)
Form SC 13D/A
08/24/2018
7:30 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/21/2018
7:30 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/20/2018
7:31 AM
China Biologic Products (Subject)
GL CAPITAL MANAGEMENT GP Ltd (Filed by)
Form SC 13D
08/20/2018
7:30 AM
China Biologic Products (Subject)
Gao David (Filed by)
Form SC 13D
08/13/2018
7:30 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2018
7:23 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2018
7:30 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2018
7:31 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2018
7:55 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/19/2018
7:30 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2018
5:09 AM
China Biologic Products (Subject)
CITIC Capital Holdings Ltd (Filed by)
Form SC 13D
06/11/2018
7:45 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2018
4:03 PM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/04/2018
4:00 PM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2018
7:30 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2018
4:17 PM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2018
3:31 PM
China Biologic Products (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/14/2018
7:45 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2018
11:27 AM
Chan Marc (Filed by)
China Biologic Products (Subject)
Form SC 13G
01/10/2018
5:05 AM
China Biologic Products (Subject)
PW Medtech Group Ltd (Filed by)
Form SC 13D
01/08/2018
7:31 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/03/2018
5:30 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/29/2017
5:01 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/15/2017
7:45 AM
China Biologic Products (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel